What is Eikon Therapeutics, Inc. 's net income?

Eikon Therapeutics, Inc. (EIKN) reported net income of -$82.96M in Q1 2026.

What does net income mean?

The bottom line — total revenue minus all expenses, taxes, and costs. Represents the profit attributable to the company's shareholders after all obligations are met.

Eikon Therapeutics, Inc. EIKN Net Income

Net Income at other companies

MYR GroupMYRG

$46.8M+101%

Cabot CorporationCBT

$68M-27.7%

Travel + LeisureTNL

$79M+8.2%

UnifirstUNF

$20.48M-16.3%

Main Street CapitalMAIN

$48.98M-57.8%

HES

Hess MidstreamHESM

$87.6M+22.3%

Other financials

Income statement

See full

Operating income-$87.3M-22.3%

EPS (diluted)-$2.46+90.9%

Balance sheet

See full

Cash & equivalents$161.2M-21.2%

Total debt$254.8M—

Total equity$550.7M+186%

Total assets$850.8M—

Cash flow

See full

Operating cash flow-$89.8M-64.7%

CapEx$262.0K-98.8%

Free cash flow-$90.1M-17.1%

Valuation

See full

Market cap$514.86M—

Where this comes from

Reported directly by Eikon Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:NetIncomeLoss.

The official record: Eikon Therapeutics, Inc. ’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Eikon Therapeutics, Inc. 's net income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Eikon Therapeutics, Inc. 's net income?: Eikon Therapeutics, Inc. (EIKN) reported net income of -$82.96M in Q1 2026.
What does net income mean?: The bottom line — total revenue minus all expenses, taxes, and costs. Represents the profit attributable to the company's shareholders after all obligations are met.